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The cytokines TNFα and IFNγ have previously been shown to activate caprine arthritis encephalitis virus (CAEV) transcription. Increased
viral titers correlate with increased lesion severity. Therefore, TNFα and IFNγ may augment the caprine arthritis lesion by increasing viral titers.
CAEV transcription is under the control of the viral promoter within the U3 region of the long terminal repeat. A set of U3 deletion mutants was
generated and used to establish stably integrated, U937-based cell lines. These cell lines were utilized to define the required promoter sequences
for cytokine-induced transcriptional activation. Here we have identified a novel 17 nucleotide TNF-activated site within the U3 region 70 bp
repeat which is both required and sufficient in a minimal construct for TNFα-induced CAEV transcriptional activation. In contrast to the results of
previous studies with IFNγ, we found that multiple sequences within the U3 region 70 bp repeat were required for IFNγ-activation of the CAEV
promoter. The results identify previously unrecognized complexity in the CAEV promoter that may be relevant to viral replication and disease.
Published by Elsevier Inc.Keywords: CAEV; LTR; SRLV promoter; TNF alpha; IFN gammaIntroduction
Caprine arthritis encephalitis virus (CAEV) and the ovine
maedi visna virus (MVV) are closely related small ruminant
lentiviruses (SRLV) that infect goats and sheep (Narayan et al.,
1980). The SRLVs are monocyte–macrophage–tropic viruses
which can induce persistent systemic diseases affecting the
synovial joints, mammary gland, lung and central nervous
system after long incubation periods (Kennedy-Stoskopf et al.,
1987) The principal clinical manifestation of CAEV infection in
goats is caprine progressive arthritis (CPA), a chronic synovitis
characterized by excessive synovial fluid accumulation, mono-
nuclear cell infiltration of the synovium, periarticular swelling,
soft tissue mineralization and erosion of articular surfaces
(Wilkerson et al., 1995).⁎ Corresponding author. Fax: +1 509 335 8529.
E-mail address: bgm@vetmed.wsu.edu (B. Murphy).
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doi:10.1016/j.virol.2007.02.020The mechanisms of CAEV pathogenesis remain controver-
sial, in particular mechanisms that continually promote
inflammation in persistent infections are incompletely under-
stood. Previous studies with SRLV have indicated that viral
persistence is maintained by restricted viral gene expression
(Gendelman et al., 1985; Peluso et al., 1985) resulting in
latently infected cells that are invulnerable to immunologic
control (Cheevers et al., 1988). However, the temporal
regulation of SRLV gene expression and the interdependent
relationship of virus and host cell gene regulation remains
poorly understood. It is known that a high CAE viral titer
correlates with the development of arthritis lesion severity
(Cheevers et al., 1988, 1991; Fluri et al., 2006; Ravazzolo et al.,
2006). Factors that augment CAE viral titers therefore likely
play a role in CPA pathogenesis. CAEV transcription depends
on the viral promoter, which resides in the U3 region of the long
terminal repeat. Within the U3 region, CAEV-CO (Cork isolate)
has two identical 70 nucleotide regions arranged as direct
repeats, referred to as 70 bp repeats. Regions homologous to the
70 bp repeat are present in other CAEV isolates. The cytokines
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interferon gamma (IFNγ) (Sepp and Tong-Starksen, 1997;
Tong-Starksen et al., 1996) have been demonstrated to activate
the CAEV promoter through mechanisms involving the CAEV
U3 region.
TNFα is considered to be a key cytokine promoting
inflammation in the human disease rheumatoid arthritis (RA)
(Lechner et al., 1996). In the CPA lesion, the pattern of cytokine
expression is similar to that found in RA (Lechner et al., 1997).
Numerous experimental observations support an association of
TNFα expression and CAEV infection. TNFα mRNA has been
detected in the joint synovium as early as 6 days after infection
with CAEV (Lechner et al., 1997) and CAEV infected goats
have elevated serum TNFα levels when compared to uninfected
control goats (Mdurvwa et al., 1994). LPS-stimulated mono-
cytes from CAEV infected goats produce 200% more TNFα
activity relative to uninfected goat monocytes (Werling et al.,
1994). Most importantly, macrophages producing abundant
TNFα mRNA have been demonstrated in synovial tissue of
goats with CPA lesions and correlate with lesion severity
(Lechner et al., 1996, 1997). Therefore, defining the role of
TNFα regulation of CAEV transcription seems critical to a
more complete understanding of CAEV pathogenesis.
Although mononuclear cells expressing IFNγ mRNA have
been identified within the CPA lesion, these cells are in the
minority relative to TNFα-expressing cells (Lechner et al.,
1997). Nevertheless, double staining experiments of CPA
lesions have revealed that some of the cells expressing viral
RNA strongly express MHC II molecules and that IFNγ-
expressing cells co-localize with areas of detectable CAEV
expression (Lechner et al., 1997). Importantly, macrophage
activation and MHC II expression is associated with exposure to
IFNγ or TNFα (Mosser, 2003). These observations suggest the
possibility that local CAEV expression is induced in part by
local production of cytokines and that TNFα may be more
important than IFNã within the chronic CPA lesion.
IFNγ-activation of CAE viral transcription is mediated
through the STAT1 pathway and requires the gamma activated
site (GAS) within the U3 region 70 bp repeat (Sepp and Tong-
Starksen, 1997). However, the dependence of IFNγ induction
on other sequences within the CAEV 70 bp repeat has not been
explored and less is known about the mechanism of TNFα in
regulating CAEV expression. The Fos-Jun heterodimer AP-1
has been shown to be required for MVV transcription (Shih et
al., 1992). We recently demonstrated that TNFα-induced
activation of CAEV transcription is independent of AP-1
(Murphy et al., 2006). Consequently, other sequences in the U3
promoter must regulate TNFα-induced expression. A more
detailed understanding of cytokine-induced signaling mechan-
isms underlying CAEV transcriptional activation may be
important as these mechanisms likely play a role in viral
persistence. Our results identify a TNF-activated site in the U3
region 70 bp repeat that functions autonomously to IFNγ
regulatory elements. Surprisingly, the GAS previously identi-
fied as an IFNγ response element (Sepp and Tong-Starksen,
1997) did not function independently within the U3 region
70 bp repeat. Results presented here clarify some regulatoryelements that exist in the CAEV promoter and indicate the
existence of additional promoter complexity.
Results
IFNγ and TNFα activate CAEV expression in U937CAEV cells
To confirm that IFNγ activates CAEV transcription in
U937CAEV cells, the cells were exposed to various concentra-
tions of recombinant human IFNγ for varying lengths of time.
Gag mRNA copy number was determined by real time RT-
PCR. U937CAEV cells exposed to 400 U IFNγ ml
−1 of media
for 0–48 h had a peak Gag mRNA expression at 4 h (Fig. 1a).
The concentration of 400 U IFNγ ml−1 has previously been
demonstrated to be the optimal concentration for IFNã
induction of the CAEV promoter (Tong-Starksen et al.,
1996). U937CAEV cells exposed to 0–400 U IFNγ ml
−1 of
media for 4 h had a dose–response activation of CAEV Gag
mRNA expression with a maximal activation at 400 U ml−1 of
media (Fig. 1b). These experiments were each repeated twice
with similar results. Treatment of U937CAEV cells with either
TNFα or IFNγ or both cytokines together (10 ng or 400 U
ml−1 media, respectively) for 4 h activated CAEV transcrip-
tion (p<0.05, Fig. 1c). The average fold-activation for TNFα
or IFNγ treated cells was 3.4- and 28-fold, respectively.
Treatment of U937CAEV cells with both TNFα and IFNγ
(10 ng and 400 U ml−1 media, respectively) did not result in
significant activation beyond that for IFNγ alone (p>0.05,
Fig. 1c). An additive or synergistic effect for cells treated with
both cytokines was therefore not identified. This experiment
was repeated three times with similar results. Samples without
reverse transcriptase (RT−) did not yield Gag amplification
products in any of these experiments, indicating that the
DNase treatment step was effective. These results demonstrate
differential activation of the CAEV promoter by TNFα and
IFNγ in the U937CAEV system and are consistent with prior
published results (Sepp and Tong-Starksen, 1997; Tong-
Starksen et al., 1996).
The U3 70 bp repeat is required for both TNFα and
IFNγ-induced activation of the CAEV promoter
In order to define promoter elements that regulate cytokine-
induced transcriptional activation, two U937 cell lines were
generated with deletions in the CAEV U3 region, U937CAEΔ1
and U937CAEΔ2 (Fig. 2a), as described previously (Murphy et
al., 2006). The U937CAEV, U937CAEΔ1 and U937CAEΔ2 cell
lines were treated with or without 10 ng TNFα ml−1 or 400 U
IFNγ ml−1 for 4 h prior to RNA harvest. The Gag mRNA copy
number was determined by real time RT-PCR. When corrected
for equal numbers of integrating constructs, cytokine treatment
of U937CAEΔ2 cells resulted in transcriptional activation
(p<0.05, Fig. 2b), while cytokine-induced activation was
abrogated in the U937CAEΔ1 cells (§, Fig. 2c). The basal
promoter function in both mutant cell lines was attenuated
relative to the U937CAEV cells (p<0.05). In these experiments,
samples without reverse transcriptase (RT−) did not yield Gag
Fig. 1. IFNγ and TNFα activate CAEV transcription in U937 cells. (a) Real-
time RT PCR time course analysis for Gag mRNA of U937CAEV cells exposed
to an initial concentration of 400 U IFNγ ml−1 media. (b) Real-time RT-PCR
dose–response analysis for Gag mRNA of U937CAEV cells exposed to 0 to
400 U IFNγ ml−1 media for 4 h. (c) Real time RT-PCR time course analysis
for Gag mRNA of U937CAEV cells without treatment or exposed to TNFα
(10 ng ml−1), IFNγ (400 U ml−1) or both cytokines together (10 ng ml−1 and
400 U ml−1, respectively) for 4 h. The difference in Gag copy number between
untreated and cytokine-treated U937CAEV cells was statistically significant
(*, p<0.05). The RT-lane corresponds to untreated control sample lacking
reverse transcriptase.
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four times with similar results.
The only difference between the U937CAEΔ2 and the
U937CAEΔ1 cells is the presence of a single copy of the 70 bprepeat in the U937CAEΔ2 cells. The loss of this repeat in the
U937CAEΔ1 cells coincides with the loss of cytokine induction.
Therefore, these results suggest that TNFα and IFNγ-induced
activation of the CAEV promoter depends on the CAEV U3
70 bp repeat.
The CAEV GAS element is necessary for IFNγ but not
TNFα-induced activation of the CAEV promoter
IFNγ activates Stat-1 phosphorylation (Krauss, 2003), and
homodimers of this transcription factor are known to bind the
CAEV gamma activated site (GAS) (Sepp and Tong-Starksen,
1997). A deletion mutant based on CAEΔ2, but lacking the U3
GAS element (CAEΔGAS), was generated to examine
cytokine-GAS dependence (Fig. 3a). The CAEΔGAS construct
has a single copy of the 70 bp repeat with a 9 nucleotide deletion
of the single remaining GAS site. A stably integrated, U937-
based cell line was generated from the CAEV mutant construct
as described in the materials and methods. The U937CAEΔ2 and
U937CAEΔGAS cell lines were treated with or without 10 ng
TNFα or 400 U IFNγ ml−1 of media for 4 h prior to RNA
harvest. When corrected for equal numbers of integrating
constructs, the U937CAEΔGAS cells had a significant level of
TNFα-induced activation (*, p<0.05), which was similar to
the level of TNFα-induced activation in U937CAEΔ2 cells.
In contrast, IFNγ-induced activation was eliminated in
U937CAEΔGAS cells (§, Fig. 3b). These results indicate that
CAEV promoter elements regulating induction by IFNγ or
TNFα are separable. This experiment was repeated three times
with similar results.
Treatment of monocytes with IFNγ induces the aggregation
the receptor complex. Subsequent recruitment of Janus kinase
JAK1 and JAK2 results in the reversible phosphorylation of the
receptor, creating a docking site for the src homology 2 domain
of Stat-1 (Greenlund et al., 1995). Stat-1 becomes tyrosine
phosphorylated, dissociates from the receptor, dimerizes and
translocates to the nucleus where it binds the GAS in the
promoters of IFNγ-inducible genes and initiates transcription.
To explore cytokine-induced phosphorylation of Stat-1, a
western blot was performed with U937CAEV cells stimulated
with or without TNFα, GM-CSF or IFNγ and evaluated for
phosphorylated STAT-1. Equivalent amounts of protein were
loaded per lane (50 ug) on two gels run in parallel. A band
corresponding to phosphorylated Stat-1 (90 kDa) was identified
in the IFNγ-treated samples but not in the other samples (Fig.
3c). The control blot incubated with anti-Stat-1 confirmed that
Stat-1 protein was present in all of the treatment groups (Fig.
3d). This experiment was repeated once with similar results.
These results demonstrate Stat-1 phosphorylation in IFNγ-
treated U937CAEV cells and a lack of Stat-1 phosphorylation in
cells that were untreated or treated with TNFα or GM-CSF. The
results are consistent with previous findings demonstrating
involvement of the Stat-1 pathway and the U3 GAS in IFNγ
activation of the CAEV promoter (Sepp and Tong-Starksen,
1997; Tong-Starksen et al., 1996). The results also support the
concept that TNFα activates CAEV expression by a promoter
element distinct from GAS.
Fig. 2. The CAEVU3 70 bp repeat is required for both TNFα and IFNγ-induced activation of the CAEV promoter in U937 cells. (a) Maps of the CAEV-CO U3 region
and derived deletion mutants. The known or predicted transcription factor binding motifs are represented as labeled black boxes and the two 70 bp repeats are denoted
by large open boxes. The U937CAEΔ2 and U937CAEΔ1 mutants have deletions in the U3 region from nucleotides 8923–9069 and 8856–9069, respectively. (b and c)
Real time RT-PCR analysis for Gag mRNA of U937CAEV, U937CAEΔ2 (b) and U937CAEΔ1 cells (c) with exposure to 10 ng TNFαml
−1 media (light grey bars), 400 U
IFNγ ml−1 media (dark grey bars) or no treatment (black bars) for 4 h. The difference in Gag copy number for TNFα or IFNγ-treated and untreated U937CAEΔ2 cells
was significant (*, p<0.05) whereas cytokine activation of the U3 promoter is abrogated in U937CAEΔ1 cells (§). The RT-lane corresponds to untreated control sample
lacking reverse transcriptase.
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activation resides in a 17 bp sequence
Since the 70 bp repeat is required for both TNFα and IFNγ-
induced activation of CAEV transcription, progressive sub-
deletions of the 70 bp repeat were generated to identify
important sequences. Four deletion mutants of the 70 bp repeat
were generated from the CAEΔ2 parent construct, as described
in the materials and methods. These deletion mutants, referred
to as CAEΔA, CAEΔB, CAEΔC and CAEΔD, are contiguous
17–20 bp deletions from the 5′ end of the 70 bp repeat (Fig. 4a).
Stably integrated, U937-based cell lines were generated from
each CAEV-mutant construct as described in the materials and
methods. A PCR reaction was performed with genomic DNA
from each cell line and the Revfor and Rrev primer set. The
resulting PCR restriction products matched the predicted PCR
product sizes for each deletion mutant (data not shown).
Each of the mutant cell lines were treated with or without
10 ng TNFα ml−1 (Figs. 4b and c) or 400 U IFNγ ml−1 (Fig.
4d) for 4 h prior to RNA harvest. The Gag mRNA copy number
was determined by real time RT-PCR. When corrected for equal
numbers of integrating constructs, TNFα-induced activationwas abrogated in U937CAEΔC cells (§, Fig. 4b), whereas TNFα-
induced promoter activation was present in the other 3 cell lines
(*, p<0.05, Figs. 4b and c). Each of these experiments was
repeated three times with similar results. In these experiments,
samples without reverse transcriptase (RT−) did not yield gag
amplification products.
These results suggest that the putative TNFα-activated site or
sites resides within the 17 nucleotide sequence deleted in the
CAEΔC construct: 5′ AAGAAAAGCAAGTTCAC. This 17
nucleotide region, identified here as the TNF-activated site
(TAS), is apparently required for TNFα-induced promoter
activation. Two additional deletion constructs were generated to
divide this region into 5′ and 3′ subregions. The constructs
CAEΔE and CAEΔF were generated from the parent construct
CAEΔ2 and have contiguous block deletions of either the 5′ end
of the C locus (5′ AAGAAAAGC) or the 3′ end (5′ AGTTC),
respectively. These constructs were utilized to generate two
U937-based cell lines, U937CAEΔE and U937CAEΔF. TNFα-
activation was abrogated in the U937CAEΔE cell line and was
attenuated in the U937CAEΔF cell line relative to U937CAEΔ2 cells
(data not shown). The 5′ AAGAAAAGC sequence within locus
C is therefore apparently required while the 3′ AGTTC sequence
Fig. 3. The U3 GAS element is necessary for IFNγ but not TNFα-induced activation of the CAEV promoter. (a) Maps of CAEΔ2 and derived deletion mutants. The
U937CAEΔ2 mutant has a U3 region deletion from nucleotides 8923–9069. The derived U937CAEΔGAS mutant has an additional deletion from nucleotides 8863–8872
(the single remaining GAS site). (b) Real time RT-PCR analysis for Gag mRNA of U937CAEΔ2 and U937CAEΔGAS cells with exposure to 10 ng TNFα ml
−1 media
(light grey bars), 400 U IFNγml−1 media (dark grey bars) or no treatment (black bars) for 4 h. The difference in Gag copy number between TNFα or IFNγ-treated and
untreated U937CAEΔ2 cells is statistically significant (*). The difference in Gag copy number between cytokine treated and untreated U937CAEΔGAS cells is statistically
significant for TNFα (*) but not IFNγ treated cells (§). There is no difference in Gag copy number between TNFα treated U937CAEΔ2 and U937CAEΔGAS cells. The
RT-lane corresponds to untreated control sample lacking reverse transcriptase. (c and d) Western blot analyses of U937CAEV cell lysates with or without exposure to
GM-CSF (50 ng ml−1), TNFα (10 ng ml−1) or IFNγ (400 U ml−1) for four h. The primary antibodies were anti-phosphorylated Stat-1 (c) or anti-Stat-1 (d).
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experiments with the U937CAEΔE cell line therefore indepen-
dently confirms the negative result of the U937CAEΔC cell line.
In contrast to the effect identified with TNFα, IFNγ-induced
promoter activation was abrogated in each of the 70 bp sub-
deletion mutants (§, p>0.05, Fig. 4d). The lack of IFNγ-
induced activation in the U937CAEΔA cell line is consistent with
results in which the GAS was deleted (U937CAEΔGAS, Fig. 3).
However, the lack of IFNγ-activation in the U937CAEΔB,
U937CAEΔC, and U937CAEΔD cell lines is an unexpected and
interesting finding. A previous study showed that a single GAS
placed upstream from a herpes simplex virus thymidine kinase
(tk) minimal promoter and a chloramphenicol acetyl transferase
(CAT) reporter gene was sufficient to activate transcription
(Sepp and Tong-Starksen, 1997).
The TNF activated site is sufficient for TNFα-induced
activation of a CAEV minimal promoter
To determine if the 17 nucleotide TAS is sufficient to confer
TNFα-induced activation, two deletion constructs were gener-ated from CAEΔ2, CAEΔI and CAEΔJ (Fig. 5a). Both of these
mutants lack the A, B and D regions of the 70 bp repeat. The
CAEΔI mutant has the 5′ portion of the U3 region placed
adjacent to TAS, while CAEΔJ lacks the 5′ U3 region. The
sizes of the constructs were confirmed by PCR analysis of
genomic DNA. The PCR products generated from U937CAEΔJ
and U937CAEΔI genomic DNAwere sequenced and determined
to be identical to the predicted sequences. Promoter activation
was induced by TNFα in the U937CAEΔ2 and U937CAEΔJ cells
(*, p<0.05, Fig. 5c). In contrast, TNFα-induced activation was
not detected in U937CAEΔI cells (§, p>0.05), indicating a lack
of TNFα responsiveness when the 5′ portion of the U3 region
was placed adjacent to TAS. These experiments were repeated
three times with similar results.
Summary of the CAEV U3 mutant basal promoter function and
cytokine induced activation
The CAEV-CO U3 promoter region and each of the derived
deletion mutants are represented schematically in Fig. 6. The
mean fold-activation by cytokine and the basal promoter
Fig. 4. A contiguous block of 17 nucleotides (region C) within the U3 70 bp repeat is required for activation of the CAEV promoter by TNFα. (a) Maps of the CAEV-
COU3 region and derived deletion mutants. The U937CAEΔ2 mutant, with a single copy of the 70 bp repeat, has a U3 region deletion from nucleotides 8923–9069. The
derived U937CAEΔA, U937CAEΔB U937CAEΔC and U937CAEΔD mutants have an additional block deletion from 8856–8872, 8873–8889, 8890–8906 and 8907–8926,
respectively. Deleted sequences are denoted by dashed lines. (b–d) Real time RT-PCR analysis for Gag mRNA of various cell lines with either no treatment (black
bars), treated with 10 ng TNFα ml−1 media (b and c, light grey bars) or 400 U IFNγ ml−1 media (d, light grey bars) for 4 h. (b and c) Only the U937CAEΔC cells were
found to be defective in TNFα-inducibility (§, p>0.05); asterisks indicate significant differences between treated and untreated cells (p<0.05). (d) No significant
differences in Gag mRNA copy numbers were identified between IFNγ-treated and untreated U937CAEΔA, U937CAEΔB, U937CAEΔC and U937CAEΔD cell lines (§). In
all the experiments, the RT-lane corresponds to untreated control sample lacking reverse transcriptase.
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level for TNFα and IFNγ are 3.4 and 28 fold, respectively. The
basal promoter activities are attenuated for the CAEΔ1 and
CAEΔ2 constructs relative to the CAEV-CO, suggesting that
the 70 bp repeat and sequences between 8998 (the 3′ end of the
70 bp repeat) and 9072 (the TATA box) contribute to CAEV
basal promoter function.
Sequence conservation within the of the U3 promoter across
multiple isolates of CAEV
The GAS and TAS appear to be important for cytokine-
induced activation of the CAEV-CO promoter. In addition,
regions B, C and D appear to be required for IFNγ-induced
CAEV expression. To assess sequence properties responsible
for these characteristics, the analogous promoter regions of
three other CAEV isolates (CAEV-1g5, -63 and -gansu) wereanalyzed to determine the level of sequence conservation. In
these isolates, the GAS and TAS had a 90.9% and 88.2%
sequence conservation, respectively (Fig. 7). By contrast, the
overall sequence conservation for the 70 bp repeat and the entire
U3 region were 78.9% and 50.9%, respectively. In the D region,
sequence conservation was 85%, and it was 82.4% for region B.
The B region conserved nucleotide distance between GAS and
TAS among the four CAEV isolates and this sequence was
biased towards G and T residues. Consequently, multiple
sequence regions that contribute to cytokine-induced activation
conserve spacing and/or nucleotide sequence.
Discussion
Previous experiments exploring cytokine-induced activation
of the CAEV promoter were performed with U3-reporter gene
constructs in episomal transient transfection assays (Sepp and
Fig. 5. Region C is sufficient for TNFα-induced activation of a CAEV minimal
promoter. (a) Maps of deletion mutants. The U937CAEΔ2 mutant has a U3 region
deletion from 8923–9069. The plasmids CAEΔI and CAEΔJ mutants were
derived from CAEΔD and have an additional deletion from 8856–8889 or
8819–8889, respectively. (b) A PCR reaction with genomic DNA isolated from
U937CAEΔJ, U937CAEΔI, U937CAEΔ2 and U937CAEV cells was performed with
the Revfor and Rrev primer set; the PCR products were electrophoresed on an
agarose gel (lanes 1–4, respectively). (c) Real time RT-PCR analysis for Gag
mRNA of U937CAEΔ2, U937CAEΔJ and U937CAEΔI cells with exposure to 10 ng
TNFαml−1 media (light grey bars) or no treatment (black bars) for 4 h. Relative
to untreated cells, TNFα-induced activation was identified for U937CAEΔ2 and
U937CAEΔJ cells (*, p<0.05). TNFα-induced activation was not identified for
U937CAEΔI cells (§). The RT-lane corresponds to untreated control sample
lacking reverse transcriptase.
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ments described here and elsewhere (Murphy et al., 2006)
utilized monocyte cell lines generated with stably integrated,
CAE proviral constructs and quantitatively assessed viral Gag
mRNA copy number as a measure of the CAEV promoter
activity. Hence, these constructs are intended to more closelyreplicate the natural host cell–viral interactions. Although U937
is a human-derived cell line, previous experiments with stably
integrated CAEV constructs have demonstrated cytokine
activation effects in both U937 cells and goat synovial
membrane cells (Murphy et al., 2006).
The most important finding presented here is the delineation
of multiple regulatory elements in the CAEV U3 promoter.
These regulatory elements appear to function by promoting
viral transcription on exposure of host cells to the cytokines
TNFα or IFNγ. Transcriptional regulation by this promoter
region is more complex than previously envisioned. It was
proposed that the AP-1 factor activates CAEV transcription by
binding AP-1-like sequences within the CAE viral promoter
(Kalinski et al., 1994). However, TNFα and GM-CSF activation
of the CAEV promoter was found to be independent of AP-1
(Murphy et al., 2006). Results described here demonstrate that a
17 nucleotide region within the U3 70 bp repeat, the TNF
activated site (TAS), is required for TNFα-induced transcrip-
tional activation. The TAS, when positioned upstream from the
TATA box, was also sufficient to support TNFα induction of
Gag transcription. However, full TNFα-induced activation may
require cooperation of both TAS elements and possibly other as
of yet unidentified LTR sequences. Furthermore, the TAS
functions autonomously to the known IFNγ response element
(GAS). Although the minimal sequence of the TAS was not
defined, data from two additional promoter subdeletions
(CAEΔE and CAEΔF) indicated that deletion of the first nine
nucleotides (5′ AAGAAAAGC) abrogated the activation while
deletion of five nucleotides near the 3′ end (5′AGTTC) reduced
TNFα-induced activation (data not shown). Therefore, we have
identified a promoter region that appears to be important for
TNFα regulation of CAEV in vitro. The transcription factor(s)
and signaling mechanism mediating TNFα-induced activation
of the U3 promoter remain undefined. However, the TAS
demonstrates some sequence similarity to a tandem repeat of
heat shock promoter elements.
In contrast to previous findings, the U3 GAS element did not
function autonomously in constructs investigated here. In
previous experiments, GAS positioned upstream from a tk
minimal promoter demonstrated that this site was sufficient to
support IFNγ-induced expression of a CAT reporter gene (Sepp
and Tong-Starksen, 1997; Tong-Starksen et al., 1996). Our
results using stably-integrated CAEV constructs showed that
the GAS is required for IFNγ-induced activation (in both the
CAEΔA and CAEΔGAS constructs). However, sequential
deletion of other sequences within the 70 bp repeat downstream
of GAS (CAEΔB, CAEΔC and CAEΔD) abrogated activation.
These findings suggest that the GAS within the context of the
isolated tk minimal promoter functions differently than
promoter sequences in the context of the CAEV genome. The
identification of additional sequences that contribute to IFNγ
inducibility may help clarify the in vivo requirements for this
response.
The abrogation of IFN-gamma inducible Gag expression by
the elimination of sequence blocks B, C or D indicated a
regulatory interaction not previously recognized for the CAEV
promoter. Several alternative explanations were considered for
Fig. 6. Summary of U3 deletion mutants and cytokine-induced fold-activation. The CAEV-CO U3 region is diagrammed schematically at the top. The deleted portion
of the promoter for each derived U3 mutant is represented as a line. The fold activation for each cytokine reflects the Gag mRNA copy number of cytokine-treated/
untreated cells (mean of 3 or more experiments). NSA and ND represent no significant activation or not determined, respectively. Basal promoter activity is defined as
the ratio of the mean copy number of unstimulated test cell line/copy number of unstimulated U937CAEV cell line (boxed). Asterisks indicate significantly different
mean copy numbers (p<0.05) for the basal promoter data.
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sequence blocks provide required spacing separating the GAS
from the TATA box, but lack a specific sequence requirement;
ii) they are conserved sequences that interact with other
regulatory factors necessary for IFNγ inducibility; or iii) they
provide required spacing, but are also conserved sequences that
interact with regulatory factors independent of IFN-gamma
inducibility (as may be the case with sequence block C, or
TAS). Promoter sequences of four CAEV isolates showed that
the location and spacing of GAS and TAS were conserved
within the 70 bp repeat. However, in addition to distance,Fig. 7. Conservation of sequences within the 70 bp U3 region of different CAEV iso
subregions is identified below the consensus sequence. The CAEV-CO isolate has tw
copy. For all of these viral isolates, the distance between the GAS and TNF activatesequences in each block (A–D) were highly conserved among
the isolates (Fig. 7). Although some variability was observed in
sequence block B, this sequence was characterized by a bias
towards G and T nucleotides (12 of 17 nucleotides). Conse-
quently, while these sequence blocks may have a spacer
function, the high degree of nucleotide conservation also
suggests roles that supercede a simple spacer function. While
conserved sequences in B and D could be candidates for
possibilities ii) or iii), our data do not allow us to distinguish
which is more likely. Essential functions of the 70 bp repeat may
remain to be clarified.lates. The GAS element is boxed. The percent conservation for each of the four
o identical copies of the 70 bp repeat, each of the other viral isolates has a single
d site is 16 nucleotides.
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nucleotides of the 5′-most U3 promoter sequence upstream of
the 70 bp repeat might have a suppressor function. TNFα-
induced activation was abrogated in U937CAEΔI cells, which
have the 5′ promoter region adjacent to TAS. An AP1-like
sequence, TGAGACA, is present within this 5′ promoter region
of all four CAEV isolates. This sequence may provide a binding
site for AP1 factors, and may function as a negative regulatory
element in CAEV transcription. In support of this possibility,
previous results demonstrated CAEV transcriptional activation
in response to treatment with a pharmacologic inhibitor of AP-1
(Murphy et al., 2006). While it is possible that this region has a
suppressor function, it is also possible that this effect is an
artifact of the construct itself. Additional research is needed to
distinguish these possibilities.
A final consideration is the effect of promoter deletion on the
basal promoter function. The basal function of the promoter was
found to be affected by deletions of sequences between the
70 bp repeat to the TATA box and as of yet undefined sequences
within the 70 bp repeat (Fig. 6). These conclusions concerning
the importance of specific sequences for basal promoter
function are essentially the same as for previously published
data (Murphy et al., 2006).
Collectively, these data provide significant resolution to an
emerging model of the CAEV promoter region. The U3 70 bp
repeat is a core promoter element and is conserved in multiple
CAEV isolates. The 70 bp repeat contains at least two distinct
regulatory elements, the GAS and TAS. Delineation of these
two regions identified adjacent regions (B and D) that conserve
spacing and nucleotide sequence among four different CAEV
isolates. In addition, a sequence 5′ to the 70 bp repeat resembles
an AP-1 binding site, which warrants investigation as a
repressor element. Since, some isolates contain two 70 bp
repeats, additional complexity in this promoter region might be
expected. The organization presented here provides specific
guidance for further delineating regulatory elements that
mediate CAEV replication and gene expression. These
considerations may be important because previous experiments
suggested that CAEV isolates with different promoter
sequences vary in virulence (Cheevers et al., 1988). While
obtained from a human cell line, our results identify sequences
that can now be investigated to determine connections between
the CAEV promoter sequences and the caprine progressive
arthritis lesion.
CAEV promoter complexity may be relevant to variable
cytokine environments encountered by the virus within the host.
For instance, IFNγ expressing lymphocytes are relatively
common in subscapular lymph nodes draining severely affected
joints (Lechner et al., 1997). In addition, IFNγ expression co-
localizes with viral RNA expression, suggesting the possibility
that this cytokine activates viral expression in adjacent
macrophages. In other studies, lymph nodes from CAEV
infected animals have been identified as important viral
reservoirs (Ravazzolo et al., 2006). These observations suggest
that IFNγmay be important in maintaining CAEVexpression in
the lymph nodes of chronically infected goats. However, within
the chronically inflamed synovial joint lesion, more cells weredetected that express TNFα than IFNγ mRNA (Lechner et al.,
1997). Under these circumstances, it is possible that TNFα
represents the dominant regulatory cytokine for CAEV
replication. Therefore the CAEV promoter region may be
adapted to respond to different cytokine environments that that
vary among different host tissues. There is precedence for local
cytokine environments differentially regulating viral transcripts
in macaques infected with the simian immunodeficiency
lentivirus (Orandle et al., 2001). With the identification of
sequence elements that regulate IFNγ and TNFα responses
of CAEV, it becomes feasible to investigate these possibilities.
Differences observed in the strength of activation by IFNγ
(28-fold) and TNFα (3.4-fold) may also be relevant to




The plasmid CAEVpac11 was generated by Dr. Isidro Hötzel
as described previously (Murphy et al., 2006). This plasmid has
the CAEV-CO strain (Cork and Narayan, 1980) proviral
sequence with a 1330 bp deletion in env and an SV40-pac
(pac: puromycin acetyltransferase) cassette replacing the tat
gene. The plasmids CAEΔ1 and CAEΔ2 were derived from
CAEVpac 11 and have a deletion between nucleotides 8856–
9069 or 8923–9069 of the CAEV-CO promoter region,
respectively. The plasmids CAEΔ1 and CAEΔ2 were generated
as described previously (Murphy et al., 2006). The plasmids
CAEΔGAS, CAEΔA, CAEΔB, CAEΔC and CAEΔD are
derived from CAEΔ2 and have additional block deletions
between nucleotides 8863–8872, 8856–8872, 8873–8889,
8890–8906 and 8907–8926, respectively. For each deletion
mutant, 5′ and 3′ primer pairs were utilized in PCR reactions to
generate 5′ and 3′ PCR products with unique restriction sites at
both ends. For the CAEΔGAS construct, the 5′ primer pair was
Revfor and GASrev while the 3′ primer pair was Rrev and GASfor.
The 5′ and 3′ primer pairs for the other constructs were as
follows—CAEΔA: Revfor/ΔArev and Rrev/GASfor; CAEΔB:
Revfor/ΔBrev and Rrev/ΔBfor; CAEΔC: Revfor/ΔCrev and Rrev/
ΔCfor and CAEΔD: Revfor/ΔDrev and Rrev/ΔDfor. The two PCR
products for each construct were ligated together and subse-
quently ligated into the pCAEVpac11 plasmid backbone
lacking the 3′ LTR.
The constructs CAEΔI and CAEΔJ were based upon the
CAEΔD and were generated in a similar manner as CAEΔA–
CAEΔD. They each have an additional block deletion between
nucleotides 8856–8889 or 8819–8889, for CAEΔI and
CAEΔJ, respectively. The 5′ and 3′ primer pairs for CAEΔI
were Revfor/ΔIrev2 and Rrev/ΔIfor; and CAEΔJ were Revfor/
ΔIrev1 and Rrev/ΔIfor. The two PCR products for each construct
were ligated together and subsequently ligated into the
pCAEVpac11 plasmid backbone lacking the 3′ LTR.
All cloning steps involving PCR were checked by sequen-
cing to confirm the absence of PCR-induced sequence errors.
The plasmid pMEVSV-G, expressing the vesicular stomatitis
205B. Murphy et al. / Virology 364 (2007) 196–207virus (VSV) G glycoprotein (utilized for packaging), was
obtained from Richard Sutton. All plasmids were propagated in
Escherichia coli JM109.
Cells and tissue culture media
The U937 cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA). U937 cells were
maintained at 37 °C in 5% CO2 in RPMI 1640 media with
L-glutamine (Gibco BRL, Grand Island, NY) supplemented with
12% fetal calf serum (FCS), 100 U penicillin L−1, 100 μg
streptomycin L−1 and 2-mercaptoethanol (2 μl 500ml−1 media).
293T cells (utilized for generating pseudotyped virus) were
grown in Dulbecco's Modified Eagle Medium (DMEM, Gibco
BRL, Grand Island NY) supplemented with 10% FCS, 100 U
penicillin L−1, 100 μg streptomycin L−1 and 2 mM L-glutamine.
Derivation of cell lines
U937 cells, along with the plasmids CAEVpac11, CAEΔ2,
CAEΔGAS, CAEΔA, CAEΔB, CAEΔC, CAEΔD, CAEΔI
and CAEΔJ were utilized to generate the cell lines: U937CAEV,
U937CAEΔ2, U937CAEΔGAS, U937CAEΔA, U937CAEΔB,
U937CAEΔC, U937CAEΔD, U937CAEΔI and U937CAEΔJ, respec-
tively. Briefly, pseudotyped virus was generated in 293T cells:
293T cells were plated in 60 mm plates and allowed to adhere
overnight. On day 2, the cells were contransfected with eight μg
of one of the CAEV plasmids and four μg pMEVSV-G using a
calcium-phosphate transfection kit (Profection Mammalian
Transfection Systems, Promega). Culture medium was replaced
24 h after transfection (day 3). Pseudotyped virus was harvested
on day 4 from media spun at 3000 rpm at 4 °C for 20 min to
remove cellular debris. U937 cells were seeded in a 25 cm2
tissue culture flask with 2 ml RPMI 10%–FCS and 2 ml of
pseudotyped virus. Control U937 cells were placed in 4 ml of
RPMI 10%–FCS without virus. The flasks were swirled every
10 min for 90 min and the volume was subsequently adjusted to
8 ml RPMI 10%–FCS per flask. Two days later (day 6), the cells
were placed in 75 cm2 flasks and the media was replaced with
RPMI 10%–FCS containing 0.5 μg puromycin ml−1. The
media was changed daily and the cells were kept in puromycin
selection for 14–21 days until 100% of the control cells were
dead. Integration of the CAEV constructs into the U937 cell
genome was confirmed by RT-PCR with total RNA utilizing
Gag and U3 primers and by PCR with genomic DNA and U3
primers (as described below).
Reagents
The recombinant human cytokines TNFα, GM-CSF and
IFNγ (R&D Systems, Inc., Minneapolis, MN), were solubilized
in PBS with 0.1% bovine serum albumin at stock concentrations
of 10 ug ml−1. The cytokines were filter sterilized and split into
50 μl aliquots. Puromycin (Sigma Aldrich) was solubilized in
water at a stock concentration of 2 mg ml−1, filter sterilized and
divided into 200 μl aliquots. All of the reagents were protected
from light and stored at −20 °C.DNA primers and probes
Primers for RT-PCR and fluorescence-interference probes
for real time PCR were ordered from Integrated DNA
technologies, Inc. (IDT, Coralville, IA). Primers were designed
as follows: CAEV Gagfor primer: 5′ ATT CTG TAATGT TCC
AGC AAC TGC; CAEV Gagrev primer: 5′ ATA TGC CAA
CTG CCT TTC AAA GTC 3′; Revfor primer: 5′ CTG ACG
ATG GGA ATC TGG ATA AAT GG; Rrev primer: 5′ AGT
GGATCC TGC GAGAGC CGC TCT; GASfor primer: 5′GGG
CTC GAG ATC ACT TGG GGG GTT ATA AGA AAA GC;
GASrev primer: 5′ CCC CTC GAG TTT GGC CTA GCT TGT
TAT TAG TCC TC; ΔArev primer: 5′ CCC CTC GAG AGC
TTG TTA TTA GTC CTC TTT AGC CC; ΔBfor primer: 5′
GGG CTC GAG AAG AAA AGC AAG TTC ACTATG ACA
AAG C; ΔBrev primer: 5′ CCC CTC GAG TTA CAG GAA
TTT GGC CTA GCT TGT TAT TAG; ΔCfor primer: 5′ GGG
CTC GAG TAT GAC AAA GCA AAA TGA GAT CTG C;
ΔCrev primer: 5′ CCC CTC GAG ATA ACC CCC CAA GTG
ATT TAC AGG; ΔDfor primer: 5′ GGG CTC GAG AGATCT
GCT GTA TAT AAG GAG AAG C; ΔDrev primer: 5′ CCC
CTC GAG GTG AAC TTG CTT TTCTTA TAA CCC; ΔIfor
primer: 5′ GGG CCATGG AAG AAA AGC AAG TTC ACC
TCG AGA GAT CTG C; ΔIrev1 primer: 5′ CCC CCA TGG
TCA CCC TTT CTT TTT TTATTT TTG TGG TGT TCT CC;
ΔIrev2 primer: 5′ CCC CCA TGG AGC TTG TTA TTA GTC
CTC TTT AGC CC; 18s rRNAfor primer: 5′ GTA ACC CGT
TGA ACC CCA TT 3′; 18s rRNArev primer: 5′ CCA TCC AAT
CGG TAG TAG CG. The primers were utilized in PCR reactions
at a final concentration of 400 nM.
The CAEV Gag fluorescence-interference probe for real
time PCR was HPLC purified (IDT, Coralville, IA) and utilized
at a final concentration of 250 nM. The Gag probe was de-
signed as follows: 5′-/5HEX/AGC AAT GCA GCATGG CCT
CGT GTC/BHQ-1/-3′ (where BHQ_1 represents Black Hole
Quencher1). The probe was protected from light and stored at
−20 °C.
RNA isolation/RT PCR assays
Total cellular RNA was purified utilizing Trizol Reagent
(Invitrogen, Carlsbad, CA). The RNAwas isolated according to
the protocol included with the kit and, if not utilized
immediately, was stored at −80 °C. DNase treatment was
accomplished with TURBO DNase (Ambion) utilizing 4 units
DNase per 3 ug total RNA and incubating the reaction for
30 min at 37 °C. The DNase was inactivated by incubating the
samples at 65 °C for 15 min. RNAwas reverse transcribed into
cDNA with the First Strand cDNA Synthesis Kit for RT-PCR
(Roche, Indianapolis, IN). A control sample was run without
reverse transcriptase to control for the DNase treatment. Real
time PCR assays were performed with Platinum Taq DNA
polymerase (Invitrogen) or iQ SYBR Green Supermix (Bio-Rad
Laboratories, Hercules, CA) on a Bio-Rad iCycler detection
system. CAEV Gag or 18s rRNA primer pairs were utilized for
real time PCR reactions; each assay was performed in triplicate.
Each experiment was performed three or more times and the
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analysis. All experiments were controlled for variations in the
reverse transcriptase step and in the RNA concentration by
normalizing to 18 s rRNA PCR products run in parallel with the
same cDNA. The normalization calculation was performed for
each sample as follows: [sample copy number/(sample 18s copy
number/control 18s copy number)]. When experiments were
performed with multiple cell lines, an integration constant was
generated by the following formula: genomic U937CAEV gag
copy number/cell line of interest genomic gag copy number.
This integration constant was then multiplied by the value
generated above to arrive at the final copy number normalized
by both the amount of 18 s rRNA and the relative number of
integrated constructs within the cell line genome.
Standard PCR was performed with Platinum Taq DNA
polymerase (Invitrogen) on a GeneAmp PCR System 9600
(Perkin Elmer). PCR products from standard RT PCR were run
on 1.5% agarose gels, stained with ethidium bromide and
digitally photographed with a Multiimage Light Cabinet (Alpha
Innotech Corporation, San Leandro, CA) utilizing Alphaimager
2200 software.
Genomic DNA isolation and PCR product sequencing
Genomic DNA was isolated from 8×105 cells utilizing a
Puregene genomic DNA isolation kit (Gentra Systems, Minnea-
polis, MN). Standard PCR was performed with the Revfor and
Rrev primer set. Genomic DNA real time PCR was performed
with CAEV Gag primers. In each cell line, the number of Gag
copies in 100 ng of genomic DNA was determined to be: 3.07,
2.10, 2.92, 1.12, 2.22, 1.90, 2.22, 2.18, 5.35, 5.13, 1.58 and 0.968
(×105, for U937CAEV, U937CAEΔ1, U937CAEΔ2, U937CAEΔGAS,
U937CAEΔA, U937CAEΔB, U937CAEΔC, U937CAEΔD,
U937CAEΔE, U937CAEΔF, U937CAEΔI and U937CAEΔJ cell
lines, respectively. This data was utilized to normalize the
number of integrated constructs between two or more cell lines in
the same experiment (see RNA isolation/RT PCR assays, above).
Western blots and protein assays
3×106 U937CAEV cells were plated in RPMI media in 6
well plates, treated with or without TNFα, GM-CSF or IFNγ
(10 ng ml−1, 50 ng ml−1 or 400 U ml−1, respectively) and
incubated for 4 h at 37 °C. The cells were washed once with PBS
and lysed with 150 μl of lysis buffer (10 mM Tris pH 7.5,
100 mM NaCl, 1 mM EDTA, 1% NP-40, 1% sodium dodecyl
sulfate, 0.5% deoxycholate). The lysates were kept on ice,
sheared by pipetting through a 20 gauge needle and filtered
through a syringe-tip filter. If not used immediately, the lysates
were stored for up to 7 days at −20 °C. The cell lysate protein
concentration was determined with a BCA Protein Assay Kit
(Pierce, Rockford, IL). The assays were run in triplicate with at
least two different sample dilutions. For each assay, a nine sample
standard curve was generated in duplicate from the kit reagents.
The sample absorption was determined on a microplate reader
(Titertek Multiskan MCC/340, EFLAB, Finland) at a wavelength
of 540 nm. The lysates were mixed with loading buffer (0.03 MTris (pH 6.8) containing 2% SDS, 10% glycerol, and 0.01%
bromphenol blue in the presence of 100 mM dithiothreitol)
(Ozyoruk et al., 2001), heated to 100 °C for 5 min and loaded
onto a 4–20% gradient polyacrylamide gel (BioRad, Hercules,
CA). The gel was run at 200 V for 30 min and transblotted onto
nitrocellulose at 100 V for 60 min. Western blotting was
performed utilizing either rabbit polyclonal anti phospho-Stat1
(Tyr 701) or rabbit polyclonal anti-Stat1 primary antibodies
(PhosphoPlus Stat1 (Tyr701 Antibody Kit, #9170, Cell Signaling
Technology, Beverly, MA) according to the kit protocol.
Sequence analysis
The CAEV-1g5 and CAEV-63 LTR regions were cloned and
sequenced in our laboratory by Isidro Hötzel (accession
EF194041 and EF194040, respectively). The CAEV-gansu
isolate was obtained from a public database (accession
AY900630). Comparison of CAEV promoter sequences was
performed utilizing Vector NTI software (Invitrogen).
Statistics
The data are presented as the mean of three or more values
(bar) with the standard deviation displayed as error bars. The
pooled data (means) from three or more independent experi-
ments was tested for violation of normality and equal variance
assumptions. If the data passed these tests, an analysis of
variance was performed (ANOVA). If the data violated either of
the two assumptions, a Kruskal–Wallis (ranks) procedure was
performed in lieu of the ANOVA. Where global differences
were identified by either procedure, the Student–Newman–
Keuls multiple comparison test was used for pair wise
comparisons of the mean responses between treatment groups.
A p value of less than 0.05 was considered to be statistically
significant. All of the figures were generated in SigmaPlot and
the statistics were performed with SigmaStat software (Systat
Software Inc. Richmond, CA).
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